Vanguard Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184M | Sell |
20,544,248
-1,115,517
| -5% | -$10M | ﹤0.01% | 1545 |
|
|
2025
Q1 | $162M | Sell |
21,659,765
-230,657
| -1% | -$1.73M | ﹤0.01% | 1568 |
|
|
2024
Q4 | $165M | Buy |
21,890,422
+1,583,826
| +8% | +$11.9M | ﹤0.01% | 1633 |
|
|
2024
Q3 | $154M | Buy |
20,306,596
+1,537,103
| +8% | +$11.7M | ﹤0.01% | 1674 |
|
|
2024
Q2 | $116M | Buy |
18,769,493
+1,092,726
| +6% | +$6.75M | ﹤0.01% | 1765 |
|
|
2024
Q1 | $89.8M | Sell |
17,676,767
-86,953
| -0.5% | -$442K | ﹤0.01% | 1919 |
|
|
2023
Q4 | $106M | Buy |
17,763,720
+2,371,401
| +15% | +$14.2M | ﹤0.01% | 1837 |
|
|
2023
Q3 | $109M | Buy |
15,392,319
+302,270
| +2% | +$2.14M | ﹤0.01% | 1759 |
|
|
2023
Q2 | $106M | Buy |
15,090,049
+263,936
| +2% | +$1.86M | ﹤0.01% | 1823 |
|
|
2023
Q1 | $124M | Buy |
14,826,113
+621,718
| +4% | +$5.19M | ﹤0.01% | 1719 |
|
|
2022
Q4 | $163M | Buy |
14,204,395
+365,783
| +3% | +$4.2M | ﹤0.01% | 1543 |
|
|
2022
Q3 | $174M | Buy |
13,838,612
+28,439
| +0.2% | +$358K | 0.01% | 1463 |
|
|
2022
Q2 | $146M | Buy |
13,810,173
+603,133
| +5% | +$6.38M | ﹤0.01% | 1612 |
|
|
2022
Q1 | $215M | Buy |
13,207,040
+3,794,135
| +40% | +$61.7M | 0.01% | 1510 |
|
|
2021
Q4 | $130M | Buy |
9,412,905
+35,857
| +0.4% | +$497K | ﹤0.01% | 1836 |
|
|
2021
Q3 | $135M | Buy |
9,377,048
+72,505
| +0.8% | +$1.04M | ﹤0.01% | 1814 |
|
|
2021
Q2 | $147M | Sell |
9,304,543
-395,524
| -4% | -$6.25M | ﹤0.01% | 1794 |
|
|
2021
Q1 | $98.6M | Sell |
9,700,067
-1,899,267
| -16% | -$19.3M | ﹤0.01% | 1954 |
|
|
2020
Q4 | $86.4M | Buy |
11,599,334
+116,302
| +1% | +$866K | ﹤0.01% | 1907 |
|
|
2020
Q3 | $39.4M | Buy |
11,483,032
+599,490
| +6% | +$2.06M | ﹤0.01% | 2128 |
|
|
2020
Q2 | $51.9M | Buy |
10,883,542
+2,111,426
| +24% | +$10.1M | ﹤0.01% | 1992 |
|
|
2020
Q1 | $17.5M | Buy |
8,772,116
+650,485
| +8% | +$1.3M | ﹤0.01% | 2359 |
|
|
2019
Q4 | $28M | Buy |
8,121,631
+2,142,710
| +36% | +$7.39M | ﹤0.01% | 2370 |
|
|
2019
Q3 | $17.1M | Sell |
5,978,921
-713,523
| -11% | -$2.04M | ﹤0.01% | 2558 |
|
|
2019
Q2 | $25.4M | Buy |
6,692,444
+648,937
| +11% | +$2.46M | ﹤0.01% | 2396 |
|
|
2019
Q1 | $49.2M | Buy |
6,043,507
+171,278
| +3% | +$1.39M | ﹤0.01% | 2088 |
|
|
2018
Q4 | $47.4M | Buy |
5,872,229
+74,000
| +1% | +$597K | ﹤0.01% | 2055 |
|
|
2018
Q3 | $44.2M | Buy |
5,798,229
+490,319
| +9% | +$3.74M | ﹤0.01% | 2207 |
|
|
2018
Q2 | $30.4M | Sell |
5,307,910
-357,847
| -6% | -$2.05M | ﹤0.01% | 2371 |
|
|
2018
Q1 | $27M | Sell |
5,665,757
-112,078
| -2% | -$535K | ﹤0.01% | 2374 |
|
|
2017
Q4 | $28.4M | Sell |
5,777,835
-229,248
| -4% | -$1.13M | ﹤0.01% | 2344 |
|
|
2017
Q3 | $31.5M | Sell |
6,007,083
-732
| -0% | -$3.84K | ﹤0.01% | 2285 |
|
|
2017
Q2 | $33.4M | Buy |
6,007,815
+996,052
| +20% | +$5.54M | ﹤0.01% | 2222 |
|
|
2017
Q1 | $42.1M | Buy |
5,011,763
+1,651,292
| +49% | +$13.9M | ﹤0.01% | 2091 |
|
|
2016
Q4 | $21.3M | Sell |
3,360,471
-196,015
| -6% | -$1.24M | ﹤0.01% | 2398 |
|
|
2016
Q3 | $15.7M | Buy |
3,556,486
+29,956
| +0.8% | +$132K | ﹤0.01% | 2479 |
|
|
2016
Q2 | $10M | Buy |
3,526,530
+283,202
| +9% | +$804K | ﹤0.01% | 2650 |
|
|
2016
Q1 | $9.18M | Buy |
3,243,328
+434,290
| +15% | +$1.23M | ﹤0.01% | 2656 |
|
|
2015
Q4 | $29M | Buy |
2,809,038
+264,452
| +10% | +$2.73M | ﹤0.01% | 2141 |
|
|
2015
Q3 | $29M | Buy |
2,544,586
+74,859
| +3% | +$853K | ﹤0.01% | 2122 |
|
|
2015
Q2 | $36.9M | Buy |
2,469,727
+8,545
| +0.3% | +$128K | ﹤0.01% | 2093 |
|
|
2015
Q1 | $22.2M | Buy |
2,461,182
+176,854
| +8% | +$1.6M | ﹤0.01% | 2279 |
|
|
2014
Q4 | $27.8M | Buy |
2,284,328
+218,191
| +11% | +$2.65M | ﹤0.01% | 2112 |
|
|
2014
Q3 | $20.2M | Buy |
2,066,137
+16,885
| +0.8% | +$165K | ﹤0.01% | 2199 |
|
|
2014
Q2 | $26.1M | Buy |
2,049,252
+264,629
| +15% | +$3.37M | ﹤0.01% | 2113 |
|
|
2014
Q1 | $18.9M | Buy |
1,784,623
+41,196
| +2% | +$436K | ﹤0.01% | 2211 |
|
|
2013
Q4 | $13.3M | Buy |
1,743,427
+81,642
| +5% | +$621K | ﹤0.01% | 2332 |
|
|
2013
Q3 | $12.1M | Buy |
1,661,785
+47,924
| +3% | +$349K | ﹤0.01% | 2310 |
|
|
2013
Q2 | $2.5M | Buy |
+1,613,861
| New | +$2.5M | ﹤0.01% | 2987 |
|